Evidence map›Paper›PMID 35213231›Full record

ArticleScience advances2022

The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation.

Victor Pui-Yan Ma, Yuesong Hu, Anna V Kellner, Joshua M Brockman, Arventh Velusamy, Aaron T Blanchard, Brian D Evavold, Ronen Alon, Khalid Salaita

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Impact of Zinc on T Cell Motility and the Immunological Synapse.International journal of molecular sciences · 2026
    Article
  8. Sono-Mechanogenetics: Linking Ultrasound Physics With Cellular Mechanobiology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Review
  10. Albumin-Bound STING Agonist Reprograms HSPCs to Antitumor Neutrophils Enhancing CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Victor Pui-Yan MaDepartment of Chemistry, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-5951-0297
Yuesong HuDepartment of Chemistry, Emory University, Atlanta, GA 30322, USA.
Anna V KellnerWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA 30332, USA.ORCID 0000-0003-0104-5334
Joshua M BrockmanWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA 30332, USA.
Arventh VelusamyDepartment of Chemistry, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0001-6230-872X
Aaron T BlanchardWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA 30332, USA.
Brian D EvavoldDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0002-3561-3494
Ronen AlonDepartment of Immunology, The Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-9161-6369
Khalid SalaitaDepartment of Chemistry, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-4138-3477
Georgia Institute of Technology · USEmory University · USUniversity of Utah · USWeizmann Institute of Science · IL

Funding

CD8 T cell antigen recognition during chronic infectionR01AI147641 · NIAID · UNIVERSITY OF UTAH · PI EVAVOLD, BRIAN D · 2020 to 2024
$3.3M
Molecular imaging technologies for mechanobiologyR01GM131099 · NIGMS · EMORY UNIVERSITY · PI MATTHEYSES, ALEXA LYNN, SALAITA, KHALID S. · 2019 to 2022
$1.6M
Developing a Bioanalytical Toolkit to Study the Mechanobiology of Juxtacrine SignalingR01GM124472 · NIGMS · EMORY UNIVERSITY · PI SALAITA, KHALID S. · 2017 to 2020
$1.5M
Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levelsK00CA223074 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MA, PUI-YAN VICTOR · 2020 to 2022
$288k
T Cell Receptor Forces: From Molecular Mapping to Cancer Therapeutic TriggeringK00CA234959 · NCI · HARVARD UNIVERSITY · PI BROCKMAN, JOSHUA MARK · 2020 to 2022
$270k
DNA mechanotechnology to investigate the role of PD1 biophysics in T cell signalingF31CA243502 · NCI · EMORY UNIVERSITY · PI KELLNER, ANNA · 2020 to 2022
$138k
The mechanical role of the glycocalyx in cancer cell adhesionF99CA245789 · NCI · EMORY UNIVERSITY · PI BLANCHARD, AARON · 2019 to 2019
$47k
NCI NIH HHS F31 CA243502NCI NIH HHS F99 CA245789NCI NIH HHS K00 CA223074NCI NIH HHS K00 CA234959NIAID NIH HHS R01 AI147641NIGMS NIH HHS R01 GM124472NIGMS NIH HHS R01 GM131099
6 · The paper itself

Abstract

T cells defend against cancer and viral infections by rapidly scanning the surface of target cells seeking specific peptide antigens. This key process in adaptive immunity is sparked upon T cell receptor (TCR) binding of antigens within cell-cell junctions stabilized by integrin (LFA-1)/intercellular adhesion molecule-1 (ICAM-1) complexes. A long-standing question in this area is whether the forces transmitted through the LFA-1/ICAM-1 complex tune T cell signaling. Here, we use spectrally encoded DNA tension probes to reveal the first maps of LFA-1 and TCR forces generated by the T cell cytoskeleton upon antigen recognition. DNA probes that control the magnitude of LFA-1 force show that

Identifiers

PMID35213231
PMCPMC8880789
OpenAlexW4214720423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.